$APOG
APOGEE ENTERPRISES, INC. Stock $apog

$apog Overview Financials Valuation SEC Filings Company Website

2013 Q2 Form 10-Q Financial Statement

#000000684513000018 Filed on July 11, 2013

Income Statement

Concept	2013 Q2	2012 Q2
Revenue	$179.3M	$154.1M
YoY Change	16.33%	0.52%
Cost Of Revenue	$142.9M	$123.1M
YoY Change	16.14%	-5.12%
Gross Profit	$36.39M	$31.08M
YoY Change	17.09%	31.2%
Gross Profit Margin	20.29%	20.16%
Selling, General & Admin	$30.27M	$28.76M
YoY Change	5.26%	6.11%
% of Gross Profit	83.19%	92.54%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.511M	$6.528M
YoY Change	-0.26%	-6.74%
% of Gross Profit	17.89%	21.01%
Operating Expenses	$30.27M	$28.76M
YoY Change	5.26%	6.11%
Operating Profit	$6.115M	$2.318M
YoY Change	163.81%	-167.9%
Interest Expense	$499.0K	$363.0K
YoY Change	37.47%
% of Operating Profit	8.16%	15.66%
Other Income/Expense, Net	$69.00K	$17.00K
YoY Change	305.88%
Pretax Income	$5.859M	$2.244M
YoY Change	161.1%	-164.11%
Income Tax	$1.700M	$638.0K
% Of Pretax Income	29.02%	28.43%
Net Earnings	$4.159M	$1.606M
YoY Change	158.97%	-173.77%
Net Earnings / Revenue	2.32%	1.04%
Basic Earnings Per Share	$0.15	$0.06
Diluted Earnings Per Share	$0.14	$0.06
COMMON SHARES
Basic Shares Outstanding	28.44M shares	27.79M shares
Diluted Shares Outstanding	29.34M shares	28.22M shares

Balance Sheet

Concept	2013 Q2	2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$66.92M	$43.90M
YoY Change	52.44%	136.02%
Cash & Equivalents	$37.15M	$23.03M
Short-Term Investments	$29.78M	$20.90M
Other Short-Term Assets	$9.300M	$21.30M
YoY Change	-56.34%	-33.02%
Inventory	$40.49M	$38.90M
Prepaid Expenses
Receivables	$117.4M	$112.0M
Other Receivables	$600.0K	$2.100M
Total Short-Term Assets	$234.7M	$218.2M
YoY Change	7.55%	5.41%
LONG-TERM ASSETS
Property, Plant & Equipment	$164.1M	$162.9M
YoY Change	0.71%	-4.63%
Goodwill	$61.38M
YoY Change
Intangibles	$13.07M
YoY Change
Long-Term Investments	$11.90M	$10.30M
YoY Change	15.53%	-31.33%
Other Assets	$7.883M	$26.80M
YoY Change	-70.59%	18.06%
Total Long-Term Assets	$262.7M	$277.4M
YoY Change	-5.31%	-5.65%
TOTAL ASSETS
Total Short-Term Assets	$234.7M	$218.2M
Total Long-Term Assets	$262.7M	$277.4M
Total Assets	$497.3M	$495.6M
YoY Change	0.35%	-1.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$32.48M	$33.70M
YoY Change	-3.61%	-9.16%
Accrued Expenses	$21.30M	$37.10M
YoY Change	-42.59%	-12.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$58.00K	$100.0K
YoY Change	-42.0%	-90.0%
Total Short-Term Liabilities	$96.74M	$99.40M
YoY Change	-2.68%	-1.19%
LONG-TERM LIABILITIES
Long-Term Debt	$20.75M	$30.90M
YoY Change	-32.86%	45.07%
Other Long-Term Liabilities	$26.10M	$41.90M
YoY Change	-37.72%	-10.28%
Total Long-Term Liabilities	$46.84M	$72.80M
YoY Change	-35.66%	7.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$96.74M	$99.40M
Total Long-Term Liabilities	$46.84M	$72.80M
Total Liabilities	$143.6M	$174.7M
YoY Change	-17.81%	-1.63%
SHAREHOLDERS EQUITY
Retained Earnings	$210.5M
YoY Change
Common Stock	$9.580M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$335.8M	$320.9M
YoY Change
Total Liabilities & Shareholders Equity	$497.3M	$495.6M
YoY Change	0.35%	-1.08%

Cashflow Statement

Concept	2013 Q2	2012 Q2
OPERATING ACTIVITIES
Net Income	$4.159M	$1.606M
YoY Change	158.97%	-173.77%
Depreciation, Depletion And Amortization	$6.511M	$6.528M
YoY Change	-0.26%	-6.74%
Cash From Operating Activities	-$2.200M	-$7.700M
YoY Change	-71.43%	-67.65%
INVESTING ACTIVITIES
Capital Expenditures	$1.512M	$9.509M
YoY Change	-84.1%	-694.31%
Acquisitions
YoY Change
Other Investing Activities	$15.90M	-$20.30M
YoY Change	-178.33%	-267.77%
Cash From Investing Activities	$14.34M	-$29.78M
YoY Change	-148.16%	-383.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net	$10.02M	$45.00K
YoY Change	22155.56%
Cash From Financing Activities	-$12.83M	$6.327M
YoY Change	-302.84%	-803.0%
NET CHANGE
Cash From Operating Activities	-2.200M	-7.700M
Cash From Investing Activities	$14.34M	-$29.78M
Cash From Financing Activities	-$12.83M	$6.327M
Net Change In Cash	$1.507M	-$23.45M
YoY Change	-106.43%	65.16%
FREE CASH FLOW
Cash From Operating Activities	-$2.200M	-$7.700M
Capital Expenditures	$1.512M	$9.509M
Free Cash Flow	-$3.712M	-$17.21M
YoY Change	-78.43%	-22.48%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	32484000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	34235000	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	121170000	USD
CY2013Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	117429000	USD
CY2013Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6923000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7081000	USD
CY2013Q2	us-gaap	Assets Assets	497330000	USD
CY2013Q1	us-gaap	Assets Assets	520141000	USD
CY2012Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	USD
CY2012Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	970000	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	56000	shares
CY2013Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	USD
CY2013Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	122624000	USD
CY2013Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	119759000	USD
CY2013Q2	us-gaap	Assets Current AssetsCurrent	234672000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	251841000	USD
CY2013Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	83147000	USD
CY2013Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	65715000	USD
CY2013Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	38927000	USD
CY2013Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	41852000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	19564000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	18506000	USD
CY2013Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	1058000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	6539000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	6504000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3915000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3945000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	1530000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	1339000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	41852000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	29777000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	29775000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost	91000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	94000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	41657000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	38814000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29775000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	26007000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	12807000	USD
CY2013Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	11882000	USD
CY2013Q2	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	41657000	USD
CY2013Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	38814000	USD
CY2013Q2	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	286000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	240000	USD
CY2013Q2	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2	192000	USD
CY2013Q2	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionAggregateLosses2	286000	USD
CY2013Q2	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2	94000	USD
CY2013Q2	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	91000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	127000	USD
CY2013Q2	us-gaap	Billings In Excess Of Cost BillingsInExcessOfCost	19304000	USD
CY2013Q1	us-gaap	Billings In Excess Of Cost BillingsInExcessOfCost	21355000	USD
CY2012Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	149000	USD
CY2013Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	298000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37147000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37767000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	23028000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54027000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	17639000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	16224000	USD
CY2012Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-31110000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-660000	USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0900
CY2012Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0900
CY2013Q1	us-gaap	Common Stock Issued Employee Stock Trust CommonStockIssuedEmployeeStockTrust	761000	USD
CY2013Q2	us-gaap	Common Stock Issued Employee Stock Trust CommonStockIssuedEmployeeStockTrust	768000	USD
CY2013Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.33
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.33
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2013Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28741227	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	28513536	shares
CY2013Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28741227	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	28513536	shares
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	9505000	USD
CY2013Q2	us-gaap	Common Stock Value CommonStockValue	9580000	USD
CY2012Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2127000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4317000	USD
CY2012Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	123059000	USD
CY2013Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	142925000	USD
CY2013Q2	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	6830000	USD
CY2013Q1	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected Within One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedWithinOneYear	3067000	USD
CY2013Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	313300000	USD
CY2013Q2	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	-768000	USD
CY2013Q1	us-gaap	Deferred Compensation Equity DeferredCompensationEquity	-761000	USD
CY2013Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	276000	USD
CY2012Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	570000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	2218000	USD
CY2013Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	1714000	USD
CY2013Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3480000	USD
CY2013Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3211000	USD
CY2012Q2	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-53000	USD
CY2013Q2	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-59000	USD
CY2013Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	46000	USD
CY2012Q2	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	44000	USD
CY2013Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	134000	USD
CY2012Q2	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	142000	USD
CY2012Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	151000	USD
CY2013Q2	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	147000	USD
CY2012Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6528000	USD
CY2013Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6511000	USD
CY2013Q2	us-gaap	Derivative Liability Fair Value Net1 DerivativeLiabilityFairValueNet1	500000	USD
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2013Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	40000	USD
CY2012Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	111000	USD
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	26732000	USD
CY2013Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16011000	USD
CY2012Q2	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	200000	USD
CY2013Q2	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	1400000	USD
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	7000000	USD
CY2013Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	500000	USD
CY2013Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1009000	USD
CY2012Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	25000	USD
CY2012Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	25000	USD
CY2013Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	1009000	USD
CY2012Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	7210000	USD
CY2013Q2	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	8789000	USD
CY2013Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	8323000	USD
CY2012Q2	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	7153000	USD
CY2013Q2	us-gaap	Extended Product Warranty Accrual Payments ExtendedProductWarrantyAccrualPayments	857000	USD
CY2012Q2	us-gaap	Extended Product Warranty Accrual Payments ExtendedProductWarrantyAccrualPayments	823000	USD
CY2013Q2	us-gaap	Extended Product Warranty Accrual Warranties Issued ExtendedProductWarrantyAccrualWarrantiesIssued	1323000	USD
CY2012Q2	us-gaap	Extended Product Warranty Accrual Warranties Issued ExtendedProductWarrantyAccrualWarrantiesIssued	766000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20043000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20364000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1367000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1050000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1147000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1296000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1643000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34218000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33360000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13675000	USD
CY2013Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13068000	USD
CY2013Q1	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	405000	USD
CY2013Q2	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	470000	USD
CY2013Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	304000	USD
CY2012Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	296000	USD
CY2013Q1	us-gaap	Goodwill Goodwill	61342000	USD
CY2013Q2	us-gaap	Goodwill Goodwill	61380000	USD
CY2012Q1	us-gaap	Goodwill Goodwill	61617000	USD
CY2013Q2	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	-38000	USD
CY2013	us-gaap	Goodwill Translation Adjustments GoodwillTranslationAdjustments	275000	USD
CY2013Q2	us-gaap	Gross Profit GrossProfit	36386000	USD
CY2012Q2	us-gaap	Gross Profit GrossProfit	31075000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5859000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2244000	USD
CY2012Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	435000	shares
CY2012Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4804000	USD
CY2012Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	638000	USD
CY2013Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1700000	USD
CY2013Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	531000	USD
CY2013Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	1371000	USD
CY2013Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11911000	USD
CY2012Q2	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10510000	USD
CY2013Q2	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	-2051000	USD
CY2012Q2	us-gaap	Increase Decrease In Billing In Excess Of Cost Of Earnings IncreaseDecreaseInBillingInExcessOfCostOfEarnings	5210000	USD
CY2013Q2	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	1425000	USD
CY2012Q2	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-3083000	USD
CY2013Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4413000	USD
CY2012Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	530000	USD
CY2013Q2	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-19000	USD
CY2012Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	3590000	USD
CY2013Q2	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-3782000	USD
CY2013Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	896000	shares
CY2013Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13675000	USD
CY2013Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13068000	USD
CY2012Q2	us-gaap	Interest Expense InterestExpense	363000	USD
CY2013Q2	us-gaap	Interest Expense InterestExpense	499000	USD
CY2013Q2	us-gaap	Interest Paid InterestPaid	200000	USD
CY2012Q2	us-gaap	Interest Paid InterestPaid	200000	USD
CY2013Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13397000	USD
CY2013Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	13347000	USD
CY2013Q2	us-gaap	Inventory Net InventoryNet	40494000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	36052000	USD
CY2013Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11834000	USD
CY2013Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	12184000	USD
CY2013Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7754000	USD
CY2013Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8133000	USD
CY2013Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	174000	USD
CY2012Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	272000	USD
CY2013Q2	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	25500000	USD
CY2013Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	497330000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	520141000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	122167000	USD
CY2013Q2	us-gaap	Liabilities Current LiabilitiesCurrent	96737000	USD
CY2013Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	470000	USD
CY2013Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	405000	USD
CY2013Q2	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	6525000	USD
CY2013Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	6765000	USD
CY2013Q2	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	0	USD
CY2013Q1	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	0	USD
CY2013Q2	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2017-10-19
CY2013Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	100000000	USD
CY2013Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	10057000	USD
CY2013Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	58000	USD
CY2013Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20756000	USD
CY2013Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	20746000	USD
CY2013Q2	us-gaap	Marketable Securities MarketableSecurities	41700000	USD
CY2013Q2	us-gaap	Minimum Net Capital Required For Entity1 MinimumNetCapitalRequiredForEntity1	335800000	USD
CY2013Q2	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	268100000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12834000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6327000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29780000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14341000	USD
CY2013Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2167000	USD
CY2012Q2	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7657000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	1606000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	4159000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7097000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7240000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	5493000	USD
CY2013Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	Segment
CY2013Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4
CY2012Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2318000	USD
CY2013Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6115000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	35166000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	6106000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3943000	USD
CY2013Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5287000	USD
CY2013Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7883000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6889000	USD
CY2013Q2	us-gaap	Other Commitment OtherCommitment	100000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	497000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	252000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	158000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	521000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	0	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-41000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	0	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-24000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	24000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-53000	USD
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-29000	USD
CY2012Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	12000	USD
CY2013Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	23643000	USD
CY2013Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	23585000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25625000	USD
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4393000	USD
CY2013Q2	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	7193000	USD
CY2013Q1	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	26443000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	211135000	USD
CY2013Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26096000	USD
CY2012Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-239000	USD
CY2013Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-231000	USD
CY2013Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	69000	USD
CY2012Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17000	USD
CY2012Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	193000	USD
CY2013Q2	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2012Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2643000	USD
CY2013Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2687000	USD
CY2012Q2	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	17040000	USD
CY2013Q2	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	10225000	USD
CY2012Q2	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	900000	USD
CY2013Q2	us-gaap	Payments To Acquire Life Insurance Policies PaymentsToAcquireLifeInsurancePolicies	0	USD
CY2012Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9509000	USD
CY2013Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1512000	USD
CY2013Q2	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	2800000	USD
CY2012Q2	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	10000000	USD
CY2013Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4782000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5452000	USD
CY2013Q2	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2012Q2	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10000000	USD
CY2013Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	6656000	USD
CY2012Q2	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	5915000	USD
CY2013Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	169000	USD
CY2012Q2	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	14000	USD
CY2013Q2	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	22053000	USD
CY2012Q2	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	1740000	USD
CY2013Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	164052000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	168948000	USD
CY2013Q2	us-gaap	Purchase Obligation PurchaseObligation	113600000	USD
CY2012Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	45000	USD
CY2013Q2	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10015000	USD
CY2013Q2	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	10000000	USD
CY2013Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2800000	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	21804000	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4639000	USD
CY2013Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	210487000	USD
CY2013Q2	us-gaap	Sales Revenue Net SalesRevenueNet	179311000	USD
CY2012Q2	us-gaap	Sales Revenue Net SalesRevenueNet	154134000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	-223225	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	13.89
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	804733	shares
CY2012Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28757000	USD
CY2013Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30271000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	16.79
CY2013Q2	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	5295000	USD
CY2013Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	6145000	USD
CY2013Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	8030000	USD
CY2013Q2	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	8247000	USD
CY2012Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1028000	USD
CY2013Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1118000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	-75547	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	13.55
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	114123	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	26.35
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	831573	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	646924	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	13.17
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	15.21
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1600000	USD
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	-7376	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	13545626	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1362373	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1105074	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.89
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	14.49
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	13545626	USD
CY2013Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-01
CY2013Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1105074	shares
CY2013Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	14.49
CY2013Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	21.98
CY2013Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	21.17
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	8037372	USD
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y4M0D
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M0D
CY2013Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y5M0D
CY2013Q2	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	1000000	USD
CY2013Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-249923	shares
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	333318000	USD
CY2013Q2	us-gaap	Stockholders Equity StockholdersEquity	335768000	USD
CY2013Q1	us-gaap	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	251000	USD
CY2013Q2	us-gaap	Trading Securities Fair Value Disclosure TradingSecuritiesFairValueDisclosure	641000	USD
CY2013Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29337000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28223000	shares
CY2012Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27788000	shares
CY2013Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28441000	shares
CY2013Q2	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	200000	USD
CY2013Q2	apog	Adjusted Debt To Ebitda Ratio AdjustedDebtToEbitdaRatio	0.00
CY2013Q2	apog	Companies Backlog Related To Sales CompaniesBacklogRelatedToSales	117100000	USD
CY2013Q2	apog	Decrease In Non Credit Facility Debt DecreaseInNonCreditFacilityDebt	25000000	USD
CY2013Q2	apog	Excess Of Non Credit Facility Debt On Unrestricted Cash Balances Cash Equivalents And Short Term Marketable Securities Available For Sale ExcessOfNonCreditFacilityDebtOnUnrestrictedCashBalancesCashEquivalentsAndShortTermMarketableSecuritiesAvailableForSale	15000000	USD
CY2013Q1	apog	Finite Lived Identifiable Intangible Assets Translation Adjustments FiniteLivedIdentifiableIntangibleAssetsTranslationAdjustments	500000	USD
CY2013Q2	apog	Finite Lived Identifiable Intangible Assets Translation Adjustments FiniteLivedIdentifiableIntangibleAssetsTranslationAdjustments	-72000	USD
CY2013Q2	apog	Mutual Fund Investments Fair Value Disclosure MutualFundInvestmentsFairValueDisclosure	600000	USD
CY2013Q2	apog	Number Of Shares Granted And Outstanding Under Incentive Plan NumberOfSharesGrantedAndOutstandingUnderIncentivePlan	117765	shares
CY2013Q2	apog	Performance Shares Cancelled PerformanceSharesCancelled	75547	shares
CY2013Q2	apog	Performance Shares Previously Granted PerformanceSharesPreviouslyGranted	174353	shares
CY2013Q2	apog	Shares Withheld For Taxes Net Of Stock Issued To Employees SharesWithheldForTaxesNetOfStockIssuedToEmployees	1141000	USD
CY2012Q2	apog	Shares Withheld For Taxes Net Of Stock Issued To Employees SharesWithheldForTaxesNetOfStockIssuedToEmployees	817000	USD
CY2013Q2	dei	Amendment Flag AmendmentFlag	false
CY2013Q2	dei	Document Period End Date DocumentPeriodEndDate	2013-06-01
CY2013Q2	dei	Document Type DocumentType	10-Q
CY2013Q2	dei	Entity Central Index Key EntityCentralIndexKey	0000006845
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28739727	shares
CY2013Q2	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2013Q2	dei	Entity Registrant Name EntityRegistrantName	APOGEE ENTERPRISES, INC.
CY2013Q2	invest	Derivative Notional Amount DerivativeNotionalAmount	24300000	USD

Files In Submission

Name	View Source	Status
0000006845-13-000018-index-headers.html	Edgar Link	pending
0000006845-13-000018-index.html	Edgar Link	pending
0000006845-13-000018.txt	Edgar Link	pending
0000006845-13-000018-xbrl.zip	Edgar Link	pending
apog-20130601.xml	Edgar Link	completed
apog-20130601.xsd	Edgar Link	pending
apog-20130601_cal.xml	Edgar Link	unprocessable
apog-20130601_def.xml	Edgar Link	unprocessable
apog-20130601_lab.xml	Edgar Link	unprocessable
apog-20130601_pre.xml	Edgar Link	unprocessable
apog-201361x10q.htm	Edgar Link	pending
apog-ex311_201361x10q.htm	Edgar Link	pending
apog-ex312_201361x10q.htm	Edgar Link	pending
apog-ex321_201361x10q.htm	Edgar Link	pending
apog-ex322_201361x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R1.xml	Edgar Link	unprocessable
R10.htm	Edgar Link	pending
R10.xml	Edgar Link	unprocessable
R11.htm	Edgar Link	pending
R11.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R12.xml	Edgar Link	unprocessable
R13.htm	Edgar Link	pending
R13.xml	Edgar Link	unprocessable
R14.htm	Edgar Link	pending
R14.xml	Edgar Link	unprocessable
R15.htm	Edgar Link	pending
R15.xml	Edgar Link	unprocessable
R16.htm	Edgar Link	pending
R16.xml	Edgar Link	unprocessable
R17.htm	Edgar Link	pending
R17.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R18.xml	Edgar Link	unprocessable
R19.htm	Edgar Link	pending
R19.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R2.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R20.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R21.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R22.xml	Edgar Link	unprocessable
R23.htm	Edgar Link	pending
R23.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R24.xml	Edgar Link	unprocessable
R25.htm	Edgar Link	pending
R25.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R26.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R27.xml	Edgar Link	unprocessable
R28.htm	Edgar Link	pending
R28.xml	Edgar Link	unprocessable
R29.htm	Edgar Link	pending
R29.xml	Edgar Link	unprocessable
R3.htm	Edgar Link	pending
R3.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R30.xml	Edgar Link	unprocessable
R31.htm	Edgar Link	pending
R31.xml	Edgar Link	unprocessable
R32.htm	Edgar Link	pending
R32.xml	Edgar Link	unprocessable
R33.htm	Edgar Link	pending
R33.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R34.xml	Edgar Link	unprocessable
R35.htm	Edgar Link	pending
R35.xml	Edgar Link	unprocessable
R36.htm	Edgar Link	pending
R36.xml	Edgar Link	unprocessable
R37.htm	Edgar Link	pending
R37.xml	Edgar Link	unprocessable
R38.htm	Edgar Link	pending
R38.xml	Edgar Link	unprocessable
R39.htm	Edgar Link	pending
R39.xml	Edgar Link	unprocessable
R4.htm	Edgar Link	pending
R4.xml	Edgar Link	unprocessable
R40.htm	Edgar Link	pending
R40.xml	Edgar Link	unprocessable
R41.htm	Edgar Link	pending
R41.xml	Edgar Link	unprocessable
R42.htm	Edgar Link	pending
R42.xml	Edgar Link	unprocessable
R43.htm	Edgar Link	pending
R43.xml	Edgar Link	unprocessable
R44.htm	Edgar Link	pending
R44.xml	Edgar Link	unprocessable
R45.htm	Edgar Link	pending
R45.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R46.xml	Edgar Link	unprocessable
R47.htm	Edgar Link	pending
R47.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R48.xml	Edgar Link	unprocessable
R49.htm	Edgar Link	pending
R49.xml	Edgar Link	unprocessable
R5.htm	Edgar Link	pending
R5.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R50.xml	Edgar Link	unprocessable
R51.htm	Edgar Link	pending
R51.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R52.xml	Edgar Link	unprocessable
R6.htm	Edgar Link	pending
R6.xml	Edgar Link	unprocessable
R7.htm	Edgar Link	pending
R7.xml	Edgar Link	unprocessable
R8.htm	Edgar Link	pending
R8.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
R9.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APOG
APOGEE ENTERPRISES, INC. Stock $apog

2013 Q2 Form 10-Q Financial Statement

#000000684513000018 Filed on July 11, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APOG APOGEE ENTERPRISES, INC. Stock $apog

2013 Q2 Form 10-Q Financial Statement

#000000684513000018 Filed on July 11, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APOG
APOGEE ENTERPRISES, INC. Stock $apog